Journal of Bone Oncology

Papers
(The H4-Index of Journal of Bone Oncology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review53
Separation surgery for metastatic epidural spinal cord compression: A qualitative review50
Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis42
New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma41
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer36
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways32
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval30
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group29
Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature28
Targeting ferroptosis in osteosarcoma26
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma24
Malignancy in giant cell tumor of bone in the extremities24
The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone22
Bone cement as a local chemotherapeutic drug delivery carrier in orthopedic oncology: A review19
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal co18
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-38418
Osteoporosis management in hematologic stem cell transplant recipients: Executive summary18
Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment18
LncRNA SNHG16 promotes epithelial-mesenchymal transition by upregulating ITGA6 through miR-488 inhibition in osteosarcoma18
Neurological outcomes after surgery for spinal metastases in symptomatic patients: Does the type of decompression play a role? A comparison between different strategies in a 10-year experience18
0.025686979293823